{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:14:06Z","timestamp":1790738046184,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12936-017-2162-8","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T13:11:27Z","timestamp":1515157887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A phase 1 evaluation of the pharmacokinetic\/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine"],"prefix":"10.1186","volume":"17","author":[{"given":"F. Joel","family":"Leong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay Prakash","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budhaditya","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"key":"2162_CR1","unstructured":"WHO. World Malaria Report 2016. Geneva: World Health Organization; 2016. p. 186. http:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2016\/report\/en\/. Accessed 2 Jan 2018"},{"key":"2162_CR2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"2162_CR3","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(14)60656-5","volume":"383","author":"NJ White","year":"2014","unstructured":"White NJ. Malaria: a molecular marker of artemisinin resistance. Lancet. 2014;383:1439\u201340.","journal-title":"Lancet"},{"key":"2162_CR4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1473-3099(15)70046-0","volume":"15","author":"D Menard","year":"2015","unstructured":"Menard D, Ariey F. Towards real-time monitoring of artemisinin resistance. Lancet Infect Dis. 2015;15:367\u20138.","journal-title":"Lancet Infect Dis."},{"key":"2162_CR5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"2162_CR6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/138161213804070302","volume":"19","author":"H Noedl","year":"2013","unstructured":"Noedl H. The need for new antimalarial drugs less prone to resistance. Curr Pharm Des. 2013;19:266\u20139.","journal-title":"Curr Pharm Des"},{"key":"2162_CR7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","volume":"15","author":"KM Tun","year":"2015","unstructured":"Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015;15:415\u201321.","journal-title":"Lancet Infect Dis."},{"key":"2162_CR8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMp1403340","volume":"371","author":"RM Packard","year":"2014","unstructured":"Packard RM. The origins of antimalarial-drug resistance. N Engl J Med. 2014;371:397\u20139.","journal-title":"N Engl J Med"},{"key":"2162_CR9","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1021\/jm300041e","volume":"55","author":"A Nagle","year":"2012","unstructured":"Nagle A, Wu T, Kuhen K, Gagaring K, Borboa R, Francek C, et al. Imidazolopiperazines: lead optimization of the second-generation antimalarial agents. J Med Chem. 2012;55:4244\u201373.","journal-title":"J Med Chem"},{"key":"2162_CR10","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1021\/jm2003359","volume":"54","author":"T Wu","year":"2011","unstructured":"Wu T, Nagle A, Kuhen K, Gagaring K, Borboa R, Francek C, et al. Imidazolopiperazines: hit to lead optimization of new antimalarial agents. J Med Chem. 2011;54:5116\u201330.","journal-title":"J Med Chem"},{"key":"2162_CR11","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/AAC.02727-13","volume":"58","author":"KL Kuhen","year":"2014","unstructured":"Kuhen KL, Chatterjee AK, Rottmann M, Gagaring K, Borboa R, Buenviaje J, et al. KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. Antimicrob Agents Chemother. 2014;58:5060\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"2162_CR12","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1128\/AAC.03478-14","volume":"58","author":"FJ Leong","year":"2014","unstructured":"Leong FJ, Zhao R, Zeng S, Magnusson B, Diagana TT, Pertel P. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers. Antimicrob Agents Chemother. 2014;58:6437\u201343.","journal-title":"Antimicrob Agents Chemother"},{"key":"2162_CR13","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJMoa1602250","volume":"375","author":"NJ White","year":"2016","unstructured":"White NJ, Duong TT, Uthaisin C, Nosten F, Phyo AP, Hanboonkunupakarn B, et al. Antimalarial activity of KAF156 in falciparum and vivax malaria. N Engl J Med. 2016;375:1152\u201360.","journal-title":"N Engl J Med"},{"key":"2162_CR14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/AAC.04181-14","volume":"59","author":"MM Plucinski","year":"2015","unstructured":"Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, et al. Efficacy of artemether\u2013lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and U\u00edge provinces, angola. Antimicrob Agents Chemother. 2015;59:437\u201343.","journal-title":"Antimicrob Agents Chemother."},{"key":"2162_CR15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.trstmh.2007.05.018","volume":"101","author":"HY Myint","year":"2007","unstructured":"Myint HY, Ashley EA, Day NPJ, Nosten F, White NJ. Efficacy and safety of dihydroartemisinin-piperaquine. Trans R Soc Trop Med Hyg. 2007;101:858\u201366.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2162_CR16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2165\/11203910-000000000-00000","volume":"72","author":"GM Keating","year":"2012","unstructured":"Keating GM. Dihydroartemisinin\/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria. Drugs. 2012;72:937\u201361.","journal-title":"Drugs."},{"key":"2162_CR17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40261-015-0312-8","volume":"35","author":"SE Reuter","year":"2015","unstructured":"Reuter SE, Evans AM, Shakib S, Lungershausen Y, Francis B, Valentini G, et al. Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin. Clin Drug Investig. 2015;35:559\u201367.","journal-title":"Clin Drug Investig."},{"key":"2162_CR18","unstructured":"European Medicines Agency. Eurartesim. EPAR summary for the public. European Medicines Agency; 2016 Jul. Report No.: EMA\/526898\/2016 EMEA\/H\/C\/001199. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/001199\/human_med_001450.jsp&mid=WC0b01ac058001d124. Accessed 2 Jan 2018"},{"key":"2162_CR19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12936-015-0664-9","volume":"14","author":"R Baiden","year":"2015","unstructured":"Baiden R, Oduro A, Halidou T, Gyapong M, Sie A, Macete E, et al. Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim\u00ae (dihydroartemisinin\/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania. Malar J. 2015;14:160.","journal-title":"Malar J."},{"key":"2162_CR20","unstructured":"European Medicines Agency\u2014Eurartesim\u2014Summary of product characteristics. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001199\/WC500118113.pdf. Accessed 15 May 2017."},{"key":"2162_CR21","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1128\/AAC.00340-15","volume":"59","author":"DS Stein","year":"2015","unstructured":"Stein DS, Jain JP, Kangas M, Lef\u00e8vre G, Machineni S, Griffin P, et al. Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquine. Antimicrob Agents Chemother. 2015;59:3493\u2013500.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-2162-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T13:11:42Z","timestamp":1515157902000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-2162-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2162"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-2162-8","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,5]]},"article-number":"7"}}